AllianceBernstein
MRVI icon

AllianceBernstein’s Maravai LifeSciences MRVI Stock Holding History

AllianceBernstein’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Sell
140,401
-18,700
-12% -$80.7K ﹤0.01% 2850
2026
Q1 		$517K Sell
159,101
-11,500
-7% -$39K ﹤0.01% 2621
2025
Q4 		$554K Sell
170,601
-17,700
-9% -$59.6K ﹤0.01% 2609
2025
Q3 		$540K Hold
188,301
– – ﹤0.01% 2634
2025
Q2 		$454K Buy
188,301
+45,781
+32% +$96.2K ﹤0.01% 2700
2025
Q1 		$315K Buy
142,520
+7,550
+6% +$29.8K ﹤0.01% 2753
2024
Q4 		$736K Hold
134,970
– – ﹤0.01% 2476
2024
Q3 		$1.12M Hold
134,970
– – ﹤0.01% 2263
2024
Q2 		$966K Sell
134,970
-36,100
-21% -$312K ﹤0.01% 2317
2024
Q1 		$1.48M Sell
171,070
-20,159
-11% -$136K ﹤0.01% 2070
2023
Q4 		$1.25M Buy
191,229
+91,777
+92% +$593K ﹤0.01% 2168
2023
Q3 		$995K Sell
99,452
-12,899
-11% -$142K ﹤0.01% 2253
2023
Q2 		$1.4M Buy
112,351
+75,861
+208% +$1.02M ﹤0.01% 2099
2023
Q1 		$511K Sell
36,490
-17,702
-33% -$254K ﹤0.01% 2559
2022
Q4 		$775K Sell
54,192
-65,688
-55% -$1.03M ﹤0.01% 2405
2022
Q3 		$3.06M Sell
119,880
-129,221
-52% -$3.24M ﹤0.01% 1629
2022
Q2 		$7.08M Sell
249,101
-206,120
-45% -$6.53M ﹤0.01% 1283
2022
Q1 		$16.1M Buy
455,221
+310,858
+215% +$10.4M 0.01% 1017
2021
Q4 		$6.05M Buy
144,363
+90,694
+169% +$3.67M ﹤0.01% 1519
2021
Q3 		$2.63M Buy
53,669
+9,600
+22% +$468K ﹤0.01% 2000
2021
Q2 		$1.84M Buy
44,069
+9,009
+26% +$349K ﹤0.01% 2244
2021
Q1 		$1.25M Buy
+35,060
New +$1.16M ﹤0.01% 2323

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

AllianceBernstein's MRVI Position: Q2 2026 in Review

AllianceBernstein reduced its Maravai LifeSciences (MRVI) stake by 12% in Q2 2026, selling an estimated $80.7K and leaving 140,401 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #2850.

AllianceBernstein first reported a position in MRVI in Q1 2021 and has held it in 22 quarters since. The position peaked at $16.1M in Q1 2022. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • AllianceBernstein held 140,401 shares of Maravai LifeSciences worth $397K as of Q2 2026.
  • AllianceBernstein sold 18,700 Maravai LifeSciences shares in Q2 2026, an estimated $80.7K.
  • Maravai LifeSciences made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2850 holding.
  • AllianceBernstein first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 22 quarters since.
  • AllianceBernstein's Maravai LifeSciences position peaked at $16.1M in Q1 2022.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.